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Manganese  overexposure  (MnOE)  can be neurotoxic.  In  humans  this  can  occur  through  occupational
exposure,  air  or  water  contamination,  well  water,  soy  milk,  and some  baby  formulas.  In children  MnOE
has  been  associated  with cognitive  and  behavioral  deﬁcits.  The  effects  of  MnOE  may  be modiﬁed  by
factors  such  as  iron  status.  We  hypothesized  that developmental  MnOE  would  be  exacerbated  by iron
deﬁciency.  A diet  with  a 90%  decrease  in  iron  (FeD)  was  given  to  gravid  female  rats  starting  on embryonic
day  15  and  continued  through  postnatal  day  (P)  28.  Mn  (100  mg/kg)  or vehicle  (VEH)  was  administered
by  gavage  every  other  day  from  P4-28.  Metal  transporters  and  receptors  (divalent  metal  transporter-
1  (DMT1),  transferrin  (Tf),  transferrin  receptor  (TfR),  and  Zrt-Irt-like  protein  8  (ZIP8))  were  quantiﬁed
in  brain  at  P28.  These  markers  were  increased  but the  changes  were  speciﬁc:  MnOE  increased  TfR  and
decreased  Tf  in  hippocampus,  whereas  FeD  increased  TfR  in  neostriatum  and  increased  TfR and  DMT1
in the  hippocampus,  and  the combination  increased  TfR  in  neostriatum  (ZIP8  was  unaffected).  Identi-
cally  treated  animals  were  tested  behaviorally  at P29  or P60.  The  combination  of FeD  + MnOE  increased
head  dips  in  an  elevated  zero-maze,  reversed  deﬁcits  in  sucrose  preference  induced  by MnOE  alone,  and
increased  spontaneous  locomotion  in an  open-ﬁeld.  Rats  were  also  evaluated  for  changes  in locomotor
activity  after  challenge  with  (±)-fenﬂuramine  (FEN,  a  5-HT  agonist:  5  mg/kg),  MK-801  (MK801,  an  NMDA
antagonist:  0.2  mg/kg),  or (+)-amphetamine  (AMPH,  a dopamine  agonist:  1 mg/kg).  Compared  with  VEH
animals, MnOE  animals  were  more  hyperactive  after  amphetamine  or MK-801,  and  were  less  inhibited
after  fenﬂuramine,  regardless  of FeD  exposure.  The  results  indicate  persistent  effects  of developmental
MnOE  on  brain  and  behavior  but few  interactions  with  dietary  iron  deﬁciency.
© 2015  The  Authors.  Published  by Elsevier  Ireland  Ltd.  This  is an  open  access  article  under  the CC. Introduction
Manganese overexposure (MnOE) can be a developmental neu-
otoxin in children [79,12,39,40,50]. A recent review shows that
igh levels of Mn  can be ingested from well water or from other
nvironmental sources and is a common route of exposure in
hildren. Such exposures are associated with cognitive deﬁcits,
ehavioral disinhibition, decreased IQ, and decreased performance
∗ Corresponding author at: Division of Neurology (MLC 7044), Cincinnati Chil-
ren’s Research Foundation, 3333 Burnet Ave., Cincinnati, OH 45229-3039, United
tates. Fax: +1 513 636 3912.
E-mail address: michael.williams@cchmc.org (M.T. Williams).
ttp://dx.doi.org/10.1016/j.toxrep.2015.07.015
214-7500/© 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access
c-nd/4.0/).BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
on school-related tasks [80]. MnOE deﬁcits are not always dose
dependent; variable concentrations in the environment above or
below recommended Center for Disease Control (CDC) and US Envi-
ronmental Protection Agency (EPA) levels are related to similar
symptoms [74,11]. Animal models of developmental MnOE  recapit-
ulate some of the signs observed in MnOE children [64,65,38,37],
but the majority of animal studies focus on striatally-dependent
deﬁcits, since these are commonly observed after adult occupa-
tional MnOE [52,51,6]. Hence, it is not clear whether children with
Mn-associated cognitive deﬁcits also have dopaminergic changes.
Moreover, the effects of MnOE can be modiﬁed by iron deﬁciency
(FeD), which is common in children of many regions.
FeD is the most common nutritional deﬁciency in the world
[47,75]. It is prevalent in women of child bearing age, especially
 article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
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regnant women, and consequently, in infants. Increased blood Mn
as been observed in children with decreased Fe stores and low fer-
itin, indicators of FeD [42,56,60]. Similar to MnOE [32], studies on
eD have often focused on possible effects on striatal dopamine
49]. FeD and MnOE symptoms often appear related to dopamin-
rgic function. In both human and animal studies, these effects
ppear as delayed sensory-motor reﬂex development, social and
xploratory deﬁcits, and sometimes cognitive deﬁcits [49].
The similarity of such deﬁcits may  be related to shared physi-
logical pathways for Fe and Mn.  Competitive inhibition has been
hown between Fe and Mn,  and FeD is associated with increased Mn
eposition in blood and brain [3,59]. Mn  and Fe share metal trans-
ort proteins, including the divalent metal transporter-1 (DMT1),
ransferrin (Tf), transferrin receptor (TfR), and Zrt-Irt-like protein
 (ZIP8) [66]. These proteins activate both Fe-independent and
ependent transport and have high afﬁnities for Mn  [62,34,73].
hese transporters are found in both the gastrointestinal system
nd brain, suggesting regulatory linkage between these two tissues.
The combination of FeD and MnOE has been investigated in
dult rodents [20,63,1,23,76,24,41], but in only one developmen-
al study [27]. In this study, the combination of FeD and MnOE
esulted in decreased pup weight, reduced hematocrit, decreased
e levels, increased brain Mn,  and increased DMT1 and TfR expres-
ion. No signiﬁcant changes in GABA or glutamate were found
n cerebellum, cortex, hippocampus, striatum, or midbrain; other
eurotransmitters were not investigated. Behavioral assessments
ere not included in this study.
Human studies investigating possible behavioral and cognitive
eﬁcits in children who are both FeD and MnOE have not been done.
etal absorption is higher in children because of their still develop-
ng gastrointestinal system; this also occurs in animals [43,21,77].
he developing nervous system is also vulnerable to toxin depo-
ition [61,5]. Therefore, MnOE in combination with FeD during
evelopment warrants further investigation.
We previously investigated developmental MnOE where pups
ere exposed to 100 mg/kg Mn  every other day from postnatal day
P) 4 to P28. Exposed pups exhibit increases in monoamine neuro-
ransmitters in multiple regions of the brain at different ages prior
o P29 [68]. For the following experiments, we combined MnOE
nd FeD by using a diet that was 90% below a standard diet in
e content. The FeD diet was given to gravid dams beginning on
mbryonic (E) day 15 and continuing until their litters were P28. We
rst investigated the combined treatment on metal transport pro-
ein expression in brain immediately after cessation of exposure to
etermine the cumulative effect of treatment. In a separate experi-
ent, we assessed behavior: anxiety using the elevated zero-maze,
nhedonia using the sucrose preference test, and probed neuro-
ransmitter functionally using selective pharmacological agents in
 locomotor test. Anxiety and activity were assessed because oth-
rs showed that developmental Mn  exposure alters anxiety-related
easures in the elevated-plus maze and open-ﬁeld [38,54]. Iron
eﬁciency can lead to depression; therefore, the sucrose preference
est was included to assess anhedonia.
. Materials and methods
.1. Animals
Male sires and nulliparous female Sprague–Dawley CD (IGS) rats
Charles River Laboratories, Raleigh, NC, strain #001) were habit-
ated for at least one week in the vivarium (AAALAC-accredited)
rior to breeding. Animals were maintained on a 14:10 h light:dark
ycle (lights on at 600 h) with controlled temperature (19 ± 1 ◦C)
nd humidity (50% ± 10%). Animals were housed in a barrier using
he Modular Animal Caging System (Alternative Design, Siloam Reports 2 (2015) 1046–1056 1047
Spring, AR). HEPA ﬁltered air was supplied to cages directly (Alter-
native Design, Siloam Spring, AR) at 30 air changes/h. Water was
provided to each cage using an automated system (SE Lab Group,
Napa, CA); NIH-07 diet was provided ad libitum except during the
FeD feeding period. A curved stainless steel enclosure was  placed in
each cage as enrichment [71]. Following cohabitation, detection of a
sperm plug counted as E0. Birth was designated as P0 and offspring
were weaned at P28 [10,57].
2.2. Iron deﬁcient diet
FeD diet was based, in part, on previous studies [35,67,45,44,46].
Pregnant females were kept on a standard NIH-07 diet until E15.
From E15 to birth dams, and after birth, litters were provided one
of two  puriﬁed diets (Land O’ Lakes Purina Feed, Evansville, IN) in
which only Fe content differed. Half the dams and litters were given
an iron sufﬁcient diet (350 ppm, FeS) and half an iron insufﬁcient
diet with a 90% decrease (35 ppm, FeD, [25]). Offspring were placed
back on the sufﬁcient NIH-07 diet at weaning (P28) and continued
on this diet throughout the remainder of the experiment.
2.3. Manganese overexposure
Litters were culled to 12. Three male and female pairs within
each litter were gavaged with 0 mg/kg Mn  (VEH: 0.01 M anhydrous
sodium chloride) or 100 mg/kg Mn  chloride (100Mn) in a volume of
3 ml/kg as previously done [30]. Gavage was used to avoid maternal
exposure and provide oral exposure. Oral intake is a common route
for developmental exposure in humans [53]. Rat pups were gavaged
every other day from P4 until P28.
2.4. Metal transport proteins
One group of animals was used for the metal transporter
experiment. These rats were sacriﬁced at P29 to assess metal
transporters in the hippocampus and neostriatum. Brains were
dissected over ice using a 1 mm brain block (Zivic-Miller, Pitts-
burgh, PA) by carving out the regions of interest from each slice as
described [28]; tissues were frozen at −80 ◦C until assayed by West-
ern blot. Frozen brain tissues were homogenized in RIPA buffer
with a protease inhibitor. Samples were spun at 4 ◦C for 20 min at
14,000 × g; protein was assayed using the BCA kit (Pierce Biotech-
nology, Rockford, IL) and then normalized. The following metal
transporters were assayed: divalent metal transport 1 (rabbitrat
DMT1, 1:5000, Alpha Diagnostic International, San Antonio, TX),
transferrin protein (rabbitTf, 1:1000, Abcam, Cambridge, MA),
transferrin receptor (TfR, 1:1000, Abcam, Cambridge, MA), and
zinc and iron-related protein 8 (also called Slc39A8; rabbitZIP8,
1:1300, Proteintech Group, Chicago, IL). Aliquots of cellular pro-
tein at either 10 g (DMT1, ZIP8, Tf, and TfR) or 25 g (Tf) and a
molecular weight standard were loaded on 12% gels under reduc-
ing conditions and blotted on PVDF membranes for 90 min  at room
temperature using the Protean Tetra system (Bio-Rad, Hercules,
CA). Blots were blocked using either 5% (DMT1, ZIP8) or 10% casein
(Tf, TfR) in Tris-buffered salt with Tween20 (0.01% TBST) for 30 min
at room temperature. Primary antibodies were incubated overnight
at 4 ◦C. After being washed, blots were incubated with goatrabbit
secondary antibody conjugated with horseradish peroxide (1:5000,
Jackson Labs, West Grove, PA) for 2 h at 4 ◦C. Immunoreactive pro-
teins were detected using enhanced chemiluminescence (Western
Bright ECL, Advansta, Menlo Park, CA) and quantiﬁed using densit-
ometry software (ImageJ, National Institutes of Health, Bethesda,
MD). Relative density was  calculated against FeS × VEH animals (4
samples per diet × Mn  combination and run in triplicate).
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Fig. 1. Study design and number of litters per condition. FeD and MnOE paradigms are the same between Western blot and behavior experiments, but litter numbers are
listed  for behavioral experiments. At E15, dams were removed from NIH-07 diet and placed on either a puriﬁed FeS or FeD diet. Nutritional content differed only in Fe content
(350  mg/g vs 35 mg/g). At P4, male and female offspring (3 per litter) were assigned to either 100 mg/kg MnCl2 or isotonic VEH. Offspring were exposed via gavage every
other  day from P4 to P28. MnOE and FeD diet ended on P28 and offspring were placed back on NIH-07 diet for the remainder of the experiment.
Fig. 2. Puriﬁed diet with a 90% decrease in Fe content given from E15 to P28 resulted in signs of FeD. For each panel, data were combined across sex and age during the
lactation period. A, FeD diet caused a 22% decrease in hematocrit in offspring. B, Brain Fe (measured by LCP–MS), was  decreased in FeD offspring compared with FeS controls.
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t,  FeD offspring were signiﬁcantly lighter than FeS controls during the preweaning
eS  controls. ***p < 0.001; ****p < 0.0001.
.5. Behavior
A separate group of animals was used for the behavioral study.
itters were culled on P1 to 12, 6 males and 6 females using a ran-
om number table to assign pups to exposure groups within litters.
ence, within each litter there were 3 male/female pairs treated
ith Mn  and 3 male/female pairs treated with vehicle. Two pairs
ithin each litter (one Mn  and one vehicle) received behavioral
esting starting on P29; two pairs within each litter (one Mn  and
ne vehicle) received behavioral testing starting on P60, and the
hird set of pairs were held and not tested and used if and only if
ne of the animals designated for behavioral testing died prior to
he start of testing. The design of the behavioral study is shown. D, During a 1 h locomotor activity test at P29, FeD offspring were less active than
in Fig. 1. Maternal weights for these litters were taken at E21, P1,
and P28. Offspring were weighed at P1, every other day throughout
MnOE, and prior to behavioral testing on P29 or P60. Offspring from
all groups within litters (Fig. 2) were tested in the following tests
beginning at P29 (young) or at P60 (adult). Behavioral testing was
conducted by personnel blind to group enrollment.
2.5.1. Elevated zero-maze
The elevated zero-maze (EZM) is a circular runway 105 cm indiameter with a 10 cm path width made of black Kydex and divided
into four equal quadrants. Two opposite quadrants have black
acrylic sidewalls (28 cm high) and two quadrants have 1.3 cm clear
acrylic curbs to prevent falls. The runway was mounted 72 cm above
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he ﬂoor [13]. Rats were placed in the center of a closed quadrant
nd behavior was scored live using a video camera connected to
 monitor outside the test room where the experimenter scored
ach behavior by direct observation. The maze was  illuminated
y a single halogen lamp (approximately 11.7 lux at the center of
he maze) and between animals the maze was cleaned with 70%
thanol. Dependent measures were: latency to open, time in open,
pen entries, and head dips. Time in open was deﬁned as the ani-
al  having both front legs past the boundary of the closed area
xtending into an open quadrant. Data were analyzed by age.
.5.2. Sucrose preference
This test was conducted on either P30 or P61 in separate animals.
n an adapted protocol [72], animals were food and water deprived
vernight for 20 h. After habituation to a new cage, animals were
xposed ad libitum to two pre-weighed water bottles (one with tap
ater and one with 1% sucrose). After 30 min, bottles were switched
ith new, pre-weighed bottles and animals were allowed ad libi-
um access for an additional 30 min. When the new bottles were
laced in the cage, the side on which the water and sucrose were
laced was reversed to prevent side preference. Sucrose preference
as determined by the decrease in weight of sucrose bottles over
he total decrease in weight of all bottles. Data were analyzed by
ge.
.5.3. Locomotor activity: baseline, saline, and drug challenge
This test was conducted the day following sucrose preference
n P31 or P62-66. Rats were placed in 40 × 40 cm2 automated
pen-ﬁeld activity monitors (PAS System, San Diego Instruments
SDI), San Diego, CA) and allowed to ambulate for 1 h then
rieﬂy removed and given a subcutaneous injection of saline (SAL,
 ml/kg), and tested another 1 h. Following the second hour, ani-
als received a subcutaneous injection of one of three drugs at
stablished doses: (±)-fenﬂuramine (FEN, a 5-HT agonist: 5 mg/kg
4,26]), MK-801 (MK801, an NMDA antagonist: 0.2 mg/kg [29]), and
+)-amphetamine (AMPH, a dopamine agonist: 1 mg/kg [33,78]).
nimals were tested for 2 h after drug challenge. This paradigm
llows for animals to act as their own control (both for drug and
njection stress) and reduces the number of animals required for
he study. Chambers were cleaned with 70% EtOH between animals.
Activity was measured by recording the total number of beam
nterruptions over each 5 min  interval. The results of the ﬁrst two
ours (habituation and saline) are presented individually for each
ge. FEN, MK-801, and AMPH results are presented separately and
ithin that section, effects of age and developmental exposure are
iscussed.
.6. Statistical analyses
Data were analyzed using mixed linear factorial analysis of vari-
nce (ANOVA; ProcMixed, SAS v9.2, SAS Institute, Cary, NC) and
nalyzed by age for behavioral studies. Between subject factors
ere diet (FeS or FeD), Mn  exposure (SAL or 100Mn), and sex (M
r F). Within subject factors were day for weight and interval for
ocomotor activity. In order to account for litter effects, litter was
reated as a randomized block factor. Randomized block designs
equire that subjects be assigned to subgroups (blocks) in which
he variability is less within blocks than between blocks, in this
ase variability within litters is less than variability between litters,
hich makes this design well suited to control for litter effects.
hen MnOE is randomly assigned within blocks, i.e., in this case
ithin litters and these factors, MnOE and sex, are therefore treated
s between subject factors since litter is already considered. Signif-
cant interactions were further analyzed using slice-effect ANOVAs
s a post hoc test. Kenward-Rodgers degrees of freedom were used.
igniﬁcance was set at p ≤ 0.05. Data are presented as least square Reports 2 (2015) 1046–1056 1049
mean ± SEM unless otherwise speciﬁed. Complete F-ratios are only
presented for diet, Mn  exposure, and their interactions; p-values
are included for everything else.
3. Results
3.1. Effectiveness of FeD
A validation experiment (8–10 litters/diet) was  performed
before the main experiment. It revealed that the FeD diet decreased
hematocrit (Hct) in both FeD dams (0.37 ± 0.03 vs. FeS: 0.47 ± 0.03,
F(1,12.5) = 4.39, p < 0.05 at E18) and pups (at P7, P14, P21, and P28:
F(1,50) = 11.49, p < 0.001; Fig. 2A). In pups, this resulted in a 22%
decrease in Hct relative to FeS diet, consistent with clinical FeD, but
not enough to qualify as anemia [8]. FeD offspring showed a signif-
icant reduction in brain Fe (repeated measures analysis at P7, P14,
P21, and P28, F(1,28) = 9.67, p < 0.001, Fig. 2B, collapsed across age.
The FeD diet also resulted in decreased pup weight during lacta-
tion (repeated measures analysis from P7 to P28 weekly weights:
F(1,114) = 17.39, p < 0.0001, Fig. 2C, weight collapsed across age).
At P28, offspring were hypoactive in a test of locomotor activity
(F(1,114) = 17.39, p < 0.0001, Fig. 2D). Hematocrit and brain Fe levels
returned to normal levels by P60 in the FeD animals (not shown).
3.2. Blood and brain manganese
Brain and blood Mn  concentrations were reported else-
where [68]. In that experiment, rats exposed to Mn  (100 mg/kg)
had signiﬁcantly increased levels of Mn  in the neostriatum
relative to VEH-treated rats (F(1,23) = 230.3, p < 0.0001), i.e.,
VEH = 0.39 ± 0.12 g/g vs. Mn100 = 2.39 ± 0.12 g/g tissue. Serum
Mn levels were somewhat elevated (F(3,31) = 1.58, p < 0.10), i.e.,
VEH = 11.67 ± 4.75 g/L vs. Mn100 = 16.62 ± 4.75 g/L.
3.3. Metal transporters
At P29, metal transporters DMT1, ZIP8, Tf, and TfR were assessed
by Western blot in the hippocampus and neostriatum to inves-
tigate how the combination of FeD diet and 100Mn exposure
affected these key markers in regions of interest. These two regions
were chosen because Mn  is closely associated in the brain with
dopamine, and dopamine is in greatest abundance in neostria-
tum. In addition, this model is being used to assess the effects of
FeD and MnOE on spatial and egocentric learning based on evi-
dence that spatial learning is largely mediated by the hippocampus
and egocentric learning is largely mediated by the striatum [14].
In the hippocampus, both DMT1 (F(1,12) = 10.86, p < 0.01) and TfR
(F(1,12) = 4.70, p < 0.05) were signiﬁcantly increased by the FeD diet
in comparison with the FeS diet (Fig. 3A), which replicates previous
studies and conﬁrms the efﬁcacy of our exposure method. Although
short of being signiﬁcant (p < 0.07), 100Mn exposure showed a ten-
dency to increase DMT1, whereas TfR protein was signiﬁcantly
increased by 100Mn exposure (F(1,4) = 19.09, p < 0.001, Fig. 3B).
Interestingly, Tf protein was  differentially decreased by a Mn × diet
interaction (F(1,12) = 6.87, p < 0.05, Fig. 3C). Although 100Mn or FeD
decreased Tf protein, the combination of FeD × 100Mn resulted in
protein levels similar to controls (Fig. 3C). ZIP8 was unaffected by
either factor or the combination.
DMT1, ZIP8, and Tf protein levels were unaffected by the devel-
opmental FeD or MnOE in the neostriatum. TfR was  increased by
FeD (F(1,9) = 6.55, p < 0.05) in the neostriatum. In this case, TfR was
affected by a Mn  × diet interaction (F(1,9) = 5.13, p < 0.05), where
FeD exposure increased protein levels, but the combination showed
a slight but signiﬁcant reduction (Fig. 3D).
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Fig. 3. Metal transporters in brain. Both FeD diet and 100Mn altered metal transport protein levels in the hippocampus and neostriatum at P29 as shown by Western blot.
A,  FeD diet signiﬁcantly increased DMT1 and TfR protein in the hippocampus. B, 100Mn exposure signiﬁcantly increased TfR in the hippocampus; DMT1 showed a nearly
signiﬁcant trend (p < 0.07), and ZIP8 and Tf protein were unaffected. C, A signiﬁcant interaction of the FeD diet and 100Mn exposure on Tf in the hippocampus showed
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rhat  protein levels were signiﬁcantly reduced by 100Mn or FeD, but not by the com
owever, the combination of the two partially, but signiﬁcantly offset the FeD effect
p  < 0.05; **p < 0.01; ***p < 0.001 vs. the FeS × VEH group.
.4. Mortality
A total of 630 animals were used in the locomotor activity
est (9–17 animals per age × sex × diet × Mn  × drug). There were 69
eaths (11% overall) of which 66 (96%) were in the 100Mn group.
eaths within each diet group were not statistically different (30
eS vs. 36 FeD pups); 61% of deaths were male.
.5. Maternal body weight and litter measures
No signiﬁcant differences in maternal weight gain were found
etween diets (not shown). There were also no signiﬁcant differ-
nces in maternal weight during lactation (not shown). The number
f pups born, sex ratio, and length of pregnancy did not differ
etween diet groups (not shown).
.6. Offspring body weight
On P1, FeD pups showed a trend toward weighing less than FeS
ups, 7.66 ± 0.32 g vs. 8.30 ± 0.29 g, respectively: F(1,490) = 3.11, < 0.08. Females weighed less than males (p < 0.0001), but there
ere no interactions with diet.
Offspring body weights from P4 to P28 were analyzed using
epeated measures ANOVA. Signiﬁcant main effects of the FeDion. D, TfR protein was signiﬁcantly increased by FeD irrespective of Mn exposure,
in was measured by relative densitometry and normalized to the FeS × VEH group.
diet (F(1,619) = 97.05, p < 0.0001) as well as a signiﬁcant inter-
action with day (F(12,6693) = 28.81, p < 0.0001) were found. FeD
animals were smaller than their FeS counterparts (collapsed across
age: 36.33 ± 0.47 g vs. 38.69 ± 0.46 g, respectively). Across days,
this decreased weight between groups became signiﬁcant by P10.
100Mn animals also weighed less than their VEH counterparts
(32.31 ± 0.46 g vs. VEH: 42.70 ± 0.47 g, F(1,619 = 249.3, p < 0.0001).
This was  also true across the exposure period (F(12,6693) = 32.88,
p < 0.0001); 100Mn animals were signiﬁcantly lighter by P6, the
second day of exposure. A signiﬁcant main effect of sex (p < 0.001)
and sex × day interaction (p < 0.001) revealed that females weighed
less than males, regardless of exposure.
Pup weights were signiﬁcantly affected by the combination
of FeD diet and 100Mn exposure during the dosing period
(F(1,619) = 5.45, p < 0.05). FeD × 100Mn offspring were signiﬁcantly
lighter than FeS × VEH animals (29.84 ± 0.69 g vs. 46.71 ± 0.62 g),
but were also signiﬁcantly lighter than offspring exposed
to either factor (FeS × 100Mn: 34.78 ± 0.61 g and FeD × VEH:
38.69 ± 0.71 g). There was  also a signiﬁcant diet × Mn  × day interac-
tion (F(12,6693) = 1.82, p < 0.05). By P8, the FeD × 100Mn offspring
weighed signiﬁcantly less than other groups (Fig. 4).
At P60 rats were weighed before the start of behavioral testing.
FeD animals were now similar in weight to FeS animals, but 100Mn-
exposed animals remained lighter compared with VEH animals
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Fig. 4. Offspring body weight. Offspring weights were signiﬁcantly decreased by FeD
diet  and 100Mn exposure and further reduced by the combination of both. Inset:
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Fig. 5. Locomotor activity: Baseline. A, During the ﬁrst hour of testing, the P29
100Mn group showed an increase in activity (photobeam interruptions) during the
habituation phase compared with VEH group from 20 min  onward (p < 0.0001). B,
(F(11,3466) = 4.34, p < 0.0001) revealed that 100Mn animals wereverage weights during the preweaning period. ****p < 0.0001.
(F(1,221) = 97.75, p < 0.0001): 100Mn: 258.61 ± 4.50 g vs. VEH:
90.88 ± 4.48 g). There was no signiﬁcant diet × Mn interaction on
ody weights at adult ages. A signiﬁcant sex × Mn  interaction con-
rmed that both 100Mn males and females were smaller than their
EH counterparts (F(1,221) = 5.74, p < 0.05). Regardless of devel-
pmental exposure, females were smaller than males as adults
p < 0.0001).
.7. Behavior
.7.1. Elevated zero-maze
At P29, there were no signiﬁcant effects of 100Mn on any
f the EZM dependent variables. However, the FeD diet, regard-
ess of 100Mn exposure, signiﬁcantly affected time spent in
pen quadrants (F(1,273) = 5.08, p < 0.05) and number of open
ntries (F(1,273) = 4.04, p < 0.05). These animals spent a shorter
ime in the open (FeD: 83.86 ± 9.05 s vs. FeS: 110.59 ± 8.03 s) and
ad a decreased number of open entries (FeD: 8.11 ± 0.77 s vs.
eS: 10.14 ± 0.68 s). Interestingly, the number of head dips was
igniﬁcantly affected by a Mn  × diet interaction (F(1,273) = 4.09,
 < 0.05). The combination of 100Mn exposure and FeD signiﬁcantly
ecreased the number of head dips compared with other groups
100Mn × FeD: 4.29 ± 0.80 vs. FeS × VEH: 6.28 ± 0.69, FeS × 100Mn:
.52 ± 0.71, FeD × VEH: 5.48 ± 0.78). Sex was not signiﬁcant and
o signiﬁcant interactions with 100Mn or FeD were noted for any
easure.
At P60, the behavioral phenotype was different for 100Mn
nimals, regardless of diet. At this age, these animals spent
ore time in the open (F(1,214) = 27.09, p < 0.0001; 100Mn:
44.82 +/−  6.51 s vs VEH: 120.07 +/- 6.54), had increased open
ntries (F(1,214) = 14.15, p < 0.0001; not shown), and although
ot signiﬁcant, had a tendency for shorter latency to ﬁrst open
uadrant entry (F(1,210) = 2.89, p < 0.09). 100Mn animals also had
ncreased head dips compared with VEH animals (F(1,214) = 14.64,
 < 0.0001; 100Mn: 8.01 +/- 0.81 vs VEH: 6.33 +/- 0.73). FeD ani-
als, now repleted, exhibited opposite patterns from their younger
ounterparts. In comparison with FeS animals, adult FeD animals
pent more time in the open (F(1,214) = 4.34, p < 0.05; not shown)
nd had increased head dips (F(1,214) = 4.13, p < 0.05; FeD: 7.97 +/-
077 vs FeS: 6.36 +/- 0.77). There were no signiﬁcant effects of
he FeD × 100Mn combination. At P60, all EZM dependent mea-
ures were signiﬁcantly affected by sex (p < 0.0001). A signiﬁcant
ex × Mn  interaction (F(1,214) = 9.13, p < 0.01) showed that the sig-
iﬁcant increased time in the open in Mn  animals was speciﬁc to
00Mn males (142.26 ± 6.15 s vs VEH: 102.32 ± 6.34 s).Adult 100Mn animals had signiﬁcantly increased activity compared with VEH ani-
mals only during minutes 40–50 (p < 0.0001). Data are shown in 5 min  intervals.
*p  < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001.
3.7.2. Sucrose preference
Sucrose preference was not signiﬁcantly affected by 100Mn
exposure at P29. It was also unaffected by FeD diet. However,
a diet × Mn  interaction revealed that FeS × 100Mn animals had
signiﬁcantly decreased sucrose preference compared with the
FeS × VEH group (F(1,271) = 4.06, p < 0.05). There were no signiﬁ-
cant effects of sex at P29.
At P60, sucrose preference was  also unaffected by 100Mn expo-
sure or FeD diet. However, a signiﬁcant sex × diet × Mn  interaction
(F(1,200) = 7.14, p < 0.01) revealed that in males, 100Mn exposure
decreased sucrose preference compared with VEH animals in the
FeS group (0.61 ± 0.02 vs. VEH: 0.67 ± 0.02).
3.7.3. Locomotor activity
3.7.3.1. Habituation. Animals tested for locomotor activity
received three phases of testing: Baseline with no treatment;
Saline with saline-only injection; and drug challenge with one of
three drugs (see [29,69,70]). At young ages, there was no signiﬁcant
main effect of diet; there was a signiﬁcant diet × interval inter-
action (F(11,3466) = 2.39, p < 0.01). Further analysis revealed that
FeD animals were signiﬁcantly hypoactive during the initial 5 min
interval (491.88 ± 19.09 vs. FeS: 595.01 ± 17.82) and maintained a
lower level of activity throughout the ﬁrst hour. Separately, there
was a signiﬁcant main effect of 100Mn exposure on activity at
the younger age (F(1,314) = 8.48, p < 0.01); 100Mn animals were
more active than controls. A signiﬁcant Mn × interval interactionmore active than VEH animals during most of the test period
(Fig. 5A). During this phase, females were also more active than
males (p < 0.01). There were no other signiﬁcant effects at this age.
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As adults, there were no signiﬁcant main effects of FeD
iet or 100Mn exposure. However, there was both a signiﬁ-
ant diet × interval interaction (F(11,2563) = 1.95, p < 0.05) and a
n × interval interaction (F(11,2563) = 5.43, p < 0.0001). FeD ani-
als were now more active than FeS animals, especially during
nitial intervals (not shown). Adult 100Mn animals exhibited the
ame pattern of activity as young 100Mn animals, i.e., a higher level
f activity during the latter half of the test session (Fig. 5B). During
his phase, females were also more active than males (p < 0.001).
here were no other signiﬁcant effects.
.7.3.2. Saline. Prior to the second hour of testing, animals were
emoved brieﬂy and injected with saline. This was done to con-
rol for the stress of removal and injection. At the young age,
00Mn animals maintained increased activity similar to the habit-
ation phase, as both a main effect (F(1,314) = 14.54, p < 0.001)
nd as an interaction with interval (F(11,3466) = 3.34, p < 0.0001).
lthough activity levels decreased over the second hour, analysis
t the last 5 min  interval revealed that 100Mn animals remained
igniﬁcantly more active compared with VEH animals (Fig. 6A).
here was no signiﬁcant main effect of FeD. Females were more
ctive than males but sex did not interact with Mn  (sex × interval
nteraction: p < 0.01). A signiﬁcant diet × sex × interval interaction
F(11,3466) = 1.81, p < 0.05) was found, but post hoc analysis using
lice effects ANOVAs revealed no signiﬁcant differences between
roups at any interval. The combination of FeD and 100Mn had no
ffect at this age, and no other signiﬁcant effects were found.bcutaneous injection of saline, A, P29 rats in the 100Mn group continued to show
ross intervals (p < 0.001). C, The adult 100Mn group remained more active than the
s. controls.
As adults, there was  a signiﬁcant main effect of 100Mn
(F(11,3466) = 1.81, p < 0.05); 100Mn animals were more active
compared with VEH animals (324.53 ± 15.48 vs. 278.14 ± 13.85).
However, there was no interaction with interval; 100Mn and VEH
groups were similar by the end of hour 2 (Fig. 6B). FeD did not sig-
niﬁcantly affect activity levels at adult ages. Females were more
active than males as before (sex × interval interaction: p < 0.01) but
sex did not interact with diet or Mn.  No combination effect of FeD
and 100Mn was seen.
3.7.3.3. Drug challenge. Activity was  signiﬁcantly affected by drug
challenge across diet, Mn,  age, and sex (p < 0.0001). This overall
effect was attributable to the general decrease in activity after FEN
dosing and increase after MK-801 or AMPH. Accordingly, separate
analyses were performed for each drug.
3.7.3.4. Fenﬂuramine. At the younger age, the FeD diet had no dif-
ferential effect on activity after FEN treatment. However, 100Mn
animals had greater activity compared with the VEH group dur-
ing the challenge period (150.08 ± 23.76 vs. VEH: 76.78 ± 20.65,
F(1,95) = 5.42, p < 0.05). There was no signiﬁcant interaction
between FeD and 100Mn treatment (Fig. 7A). Sex did not affect
activity, but there was a signiﬁcant sex × diet × interval interac-
tion (F(23,2185) = 1.7, p < 0.05). Post hoc analysis using slice effect
ANOVAs revealed that during initial intervals FeD females were
more active compared with other groups, but this effect dissipated
during the later intervals.
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Fig. 7. Locomotor activity at P29: Drug challenge: During hours 3 and 4, activity was
monitored following subcutaneous injection with one of three drugs. A, Challenge
with (±)-fenﬂuramine (FEN), a 5-HT agonist. The 100Mn groups had signiﬁcantly
increased activity compared with VEH animals, regardless of diet (p < 0.05); no
other effects were signiﬁcant. B, Challenge with the indirect dopaminergic agonist
(+)-amphetamine (AMPH). The 100Mn groups, regardless of diet, had signiﬁcantly
increased activity compared with VEH animals (p < 0.05). C, Challenge with the
NMDA receptor irreversible antagonist MK-801. The 100Mn groups showed sig-
niﬁcantly increased activity compared with VEH groups regardless of diet (p < 0.05). Reports 2 (2015) 1046–1056 1053
As adults, there were no signiﬁcant effects of FeD diet or 100Mn
exposure after FEN treatment (not shown). There was also no sig-
niﬁcant diet × Mn  interaction. Although there was  no signiﬁcant
main effect of sex, there was a signiﬁcant sex × interval interaction
(p < 0.001); females were more active during most intervals than
males.
3.7.3.5. Amphetamine. In younger animals, FeD did not signiﬁ-
cantly affect activity after AMPH treatment. However, 100Mn
exposure signiﬁcantly increased activity after AMPH more
than in controls (main effect: F(1,106) = 4.97, p < 0.05, 100Mn:
1066.68 ± 51.98 vs. VEH: 902.74 ± 51.98). This was also true across
intervals (Mn  × interval interaction: F(23,2438) = 3.16, p < 0.0001).
A diet × Mn  interaction approached signiﬁcance (F(1,106) = 3.48,
p < 0.07; (Fig. 7B)). Although sex was  not signiﬁcant, there was a sig-
niﬁcant sex × interval interaction (p < 0.0001) showing that females
maintained higher levels of activity after AMPH than males. There
were no other signiﬁcant main effects or interactions.
As adults, there were no signiﬁcant differential effects of FeD,
100Mn, or the interaction of the two as a function of AMPH-
induced hyperactivity (not shown). Sex was  not signiﬁcant, but
there was  a signiﬁcant sex × interval interaction (p < 0.0001) that
showed females were more active after AMPH than males. There
were no other signiﬁcant main effects or interactions.
3.7.3.6. MK-801. In the younger animals, there was no signiﬁcant
effect of FeD diet on activity after MK-801 treatment. A signiﬁcant
main effect of 100Mn exposure (F(1,96.9) = 5.88, p < 0.05) revealed
that 100Mn animals were more hyperactive after MK-801 than con-
trols (733.79 ± 51.53 vs. VEH: 569.69 ± 43.88), but there was no
interaction with interval. There was  also no interaction between
FeD and 100Mn following MK-801 (Fig. 7C). A signiﬁcant main
effect of sex revealed that males had increased beam breaks com-
pared with females after MK-801 treatment (p < 0.05) and that this
was true over time (p < 0.0001). No other interactions were signif-
icant.
As adults, there were no signiﬁcant differential effects of
FeD diet or 100Mn exposure on activity following MK-801 (not
shown). There was  also no interaction between the FeD diet and
100Mn on activity after MK-801. A signiﬁcant main effect of
sex revealed that males again had increased hyperactivity after
MK-801 compared with females (p < 0.01) and that this was true
across intervals (p < 0.0001). A signiﬁcant diet × sex interaction
(F(1,73) = 4.59, p < 0.05) showed that FeD males had the highest
activity compared with other sex × diet groups (1228.39 ± 93.65
vs. FeS males: 942.68 ± 90.49, FeS females: 846.44 ± 90.48, and
FeD females: 736.82 ± 94.27). This higher activity was  maintained
across intervals as shown by a signiﬁcant sex × diet × interval
interaction (F(23,1675) = 2.01, p < 0.01). No other interactions were
signiﬁcant.
4. Discussion
This study examined the interaction between FeD and MnOE
in a rat model of relevant childhood exposures. Both FeD and
MnOE cause neurocognitive and behavioral deﬁcits in children,
hence investigating the combination is important. While others
have examined FeD and MnOE in adult animals [19,23], there
is a dearth of developmental data on this combination. This set
of experiments sought to examine how FeD and MnOE interact
during development to affect metal transport protein status and
behavior.We found evidence for FeD and MnOE interaction on metal
transport proteins in the hippocampus. A signiﬁcant diet × Mn
interaction for Tf protein in the hippocampus showed that
FeD × 100Mn increased protein levels back to FeS × VEH levels. This
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as an unanticipated result and suggests that increased Mn  expo-
ure during FeD binds Tf, elevating circulating protein levels even
hen the Fe is low. However, the TfR protein was not signiﬁcantly
hanged by a FeD × 100Mn interaction showing that receptor num-
er was unaffected.
Animals in the behavioral experiment were weighed prior to
eaning as a measure of general health. Although FeD and Mn
xposed animals were lighter than controls during nursing, and
he combination exacerbated the decrease in body weight. These
esults are similar to previous studies [27,35,67,46]. Smaller body
eights in young children are correlated with suboptimal neurode-
elopmental outcomes [2]. This interaction was transient, however,
nd disappeared by P60.
At P29, FeD × 100Mn animals had decreased head dips in the
ZM, but no other effects were noted on this test. FeD × 100Mn
nimals had decreased sucrose preference at P30, and this was  also
een in FeD × 100Mn males at P61. Taken together, the data sug-
est that the combination of exposures results in increased anxiety,
ecreased exploration, and anhedonia.
Overall, treatment with fenﬂuramine decreased locomotor
ctivity. MnOE attenuated this fenﬂuramine-induced activity
eduction resulting in the MnOE animals remaining more active
han the non-MnOE groups. The FeD diet and 100Mn combination
id not signiﬁcantly affect locomotor activity habituation or the
esponse to saline in the open-ﬁeld test. Likewise, the combina-
ion did not cause differences in response to FEN or MK-801 on
ocomotor activity at either age. Although only a trend, FeD × VEH
nimals had decreased locomotor activity compared with other
iet × Mn  groups after AMPH at P29. The FeD × Mn combination
ad the greatest effect on activity during the early intervals after
EN injection. Looked at another way, the addition of MnOE to
nimals on the FeD diet ameliorated their reduced activity after
enﬂuramine. The reasons behind this are unclear, but align with
he pattern seen with Tf protein levels. This was not seen at adult
ges. Also, at P29, amphetamine increased activity in all groups,
owever, further along in testing, the FeS-MnOE group remained
ess hyperactive in response to amphetamine than all other groups.
The FeD diet alone had modest effects. FeD increased DMT1 and
fR in the hippocampus and TfR in the neostriatum. This is simi-
ar to previous studies [27] and suggests that Fe stores were low
n the brain and expression was increased in order to compensate
nd transport more Fe into these regions. As expected, FeD animals
ere smaller during lactation. After weaning, FeD animals were
laced back on a FeS diet, and they showed recovery of body weight
y P60, indicating Fe repletion. This was conﬁrmed by hematocrit
nd brain Fe levels that were similar to FeS animals at P60. The
ffects of Fe repletion were also seen in behavioral measures, par-
icularly in the EZM. At younger ages, FeD animals were hypoactive
n the EZM based on the decrease in the number of open entries and
ime spent in the open quadrants that suggested increased anxi-
ty. We  also found hypoactivity in locomotor testing and this was
hown before [67]. Some of the changes seen at P29 were no longer
resent at P60, i.e., FeD animals at P60 exhibited increased time
n the open and increased head dips in the EZM compared with
eS animals; also, adult FeD animals were hyperactive compared
ith FeS animals during the ﬁrst hour of the open-ﬁeld test. FeD
epletion can reverse many effects of neonatal FeD in humans and
nimals [35,67,9,16].
Pharmacological challenge revealed no effects of FeD on neu-
otransmitter functionality regardless of age. There were some
ex-speciﬁc effects, but these were transient. Our paradigm was
ntended to mimic  moderate FeD [46,45,44], and dietary iron lev-
ls reﬂect this, being sufﬁcient for growth (except during lactation).
his moderate deﬁciency may  explain the lack of effects on behav-
or despite other FeD indicators. Reports 2 (2015) 1046–1056
Mn  exposure, on the other hand, resulted in a number of adverse
effects. First, Mn  exposure increased offspring mortality, increased
DMT1 in the hippocampus with no effect in the neostriatum. Sec-
ond, Mn-exposed animals were lighter than VEH animals. There
were no signiﬁcant effects of developmental MnOE on EZM at
P29. This makes the P60 phenotype more striking; in this test
100Mn animals spent signiﬁcantly more time in the open, and had
increased open entries; this suggests hyperactivity or decreased
anxiety. Increased activity during the initial phase of open-ﬁeld
testing lends support to the idea of hyperactivity. 100Mn animals
had increased head dips in comparison with VEH animals which
also suggest a reduction in anxiety. However, being in open areas
longer exposes an animal to potential threats so this is not nec-
essarily a beneﬁcial response. This is important to remember in
light of previous work suggesting that MnOE is associated with
behavioral disinhibition [38]. 100Mn animals also had a decreased
sucrose preference, suggesting anhedonia, which is a characteristic
not typically associated with decreased anxiety. This may  suggest
behavioral disinhibition, but neophobia could also explain these
results. Decreases in anxiety and other evidence of behavioral dis-
inhibition in the literature on developmental MnOE vary. Several
studies found no differences between Mn  and controls in the ele-
vated plus maze (EPM) [55,38], but others report decreased anxiety
in EPM or increased center activity in the open-ﬁeld [38,54]. Mn  is
known to have increased deposition in the basal ganglia [17], which
may  contribute to reduced anxiety and behavioral disinhibition.
100Mn animals had increased ambulation compared with VEH
animals in both the habituation and saline phases of the open-ﬁeld.
This ﬁts with previously published data [38]. Young 100Mn animals
retained this hyperactivity after being challenged with FEN; the
opposite was  seen in VEH animals. Sustained ambulation suggests
a decrease in neurotransmitter release or a decrease in receptor
function. Either way, this study is the ﬁrst to link MnOE and sero-
tonergic alterations. IQ decreases and cognitive deﬁcits in children
have been linked to dysfunctional serotonergic systems [48].
100Mn animals also exhibited exacerbated hyperactivity after
challenge with MK-801 at younger ages. MK-801 induced hyper-
activity has been linked to increases in dopaminergic function as
well as NMDA receptor inactivation [15,58]. Mn2+ is a competitive
antagonist of NMDA receptors [22,36], excess Mn2+ likely perme-
ate ion channels and inhibit receptor function [31]. In this case,
hyperactivity following MK-801 challenge could be the result of
increased DA as shown previously [68].
Increased DA function is supported by the increased ambu-
lation after AMPH challenge at young ages in 100Mn animals.
Developmental MnOE is known to alter DA receptors and trans-
porters [64,65,38,37]. Greater ambulation in young MnOE animals
may  suggest presynaptic changes consistent with excess DA in the
nerve terminals. Others have reported increased extracellular DA
in MnOE animals [18,7].
The results suggest that developmental MnOE produces alter-
ations on neurotransmitter systems at younger ages. However, we
saw no differences between 100Mn and VEH animals as adults in
the pharmacological challenge experiment. Mn  deposition in the
brain could be responsible for the age-dependent effects; younger
animals have higher Mn  concentrations due to the proximity of
testing to the end of dosing. This implies that neurotransmitter
function returned to normal at adult ages after a recovery period
although the EZM and sucrose preference results show that some
effects persist.
In conclusion, the intention was to investigate the combination
of FeD and MnOE on brain development and function. Although
we saw some deﬁcits related to an interaction, most of our results
were related to the effects of each factor acting separately. The
FeD diet produced transient effects which dissipated following Fe
repletion. More importantly, we  report that developmental MnOE
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lters neurotransmitters beyond dopamine, i.e, MnOE also affected
erotonergic and glutamatergic function using pharmacological
ethods. Children with MnOE exhibit deﬁcits in a wide range of
ehaviors and cognitive functions, suggesting that modeling such
ffects could be used to investigate the mechanisms behind such
ffects.
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